Jun. 2 at 7:07 PM
$LCTX “The FDA, which did not mention any companies by name, said those with products using the same cell expansion platform “may consider leveraging process parameters, analytical methods, and manufacturing data across their product portfolio.” Companies like Gilead Sciences and Bristol Myers Squibb have won approval for multiple CAR-T therapies using the same cell expansion platform.“ Endpoints Pharma
